跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 534 条关于
“Debio 2512”
全部
534
临床试验
189
药物
295
机构
0
资讯
50
11个月前
Debiopharm Advances Bispecific ADC Development with SunRock Biopharma's Anti-HER2/HER3 Antibody License
9个月前
Debiopharm Initiates Phase III Trial for Quarterly Acromegaly Treatment Debio 4126
去年
Debiopharm Initiates First-in-Human Trial of CD37-Targeted ADC Debio 1562M for Relapsed/Refractory AML
去年
CARB-X Awards Debiopharm Additional $12.3 Million to Advance Novel Antibiotic Debio 1453 Against Drug-Resistant Gonorrhea
10个月前
Debiopharm Completes Enrollment for First-Ever Yearly Injectable Triptorelin Formulation in Pediatric Central Precocious Puberty Trial
去年
First Patient Dosed in Novel Breast Cancer Trial Combining WEE1 Inhibitor with Trodelvy
5个月前
Debiopharm Reports First Clinical Data from MYTHIC Trial Combining WEE1 and PKMYT1 Inhibitors at AACR 2026
去年
Repare Therapeutics Licenses PKMYT1 Inhibitor Lunresertib to Debiopharm in $267M Deal
去年
ITM and Debiopharm Initiate New Study Arm for CAIX-Targeted Theranostic in Clear Cell Renal Cell Carcinoma
去年
REDUCE-AMI Trial Re-evaluates Beta-Blocker Use Post-Myocardial Infarction
第 1 页,共 5 页
上一页
下一页